NPs Basic Information

Name
Palmarumycin B4
Molecular Formula C20H20O8
IUPAC Name*
(1S,2S,3S,4R,6S,7R,10S)-spiro[11-oxatricyclo[4.4.1.01,6]undecane-5,3'-2,4-dioxatricyclo[7.3.1.05,13]trideca-1(12),5,7,9(13),10-pentaene]-2,3,4,7,10-pentol
SMILES
C1C[C@H]([C@@]23[C@@]([C@H]1O)(O2)[C@H]([C@@H]([C@H](C34OC5=CC=CC6=C5C(=CC=C6)O4)O)O)O)O
InChI
InChI=1S/C20H20O8/c21-12-7-8-13(22)19-18(12,28-19)16(24)15(23)17(25)20(19)26-10-5-1-3-9-4-2-6-11(27-20)14(9)10/h1-6,12-13,15-17,21-25H,7-8H2/t12-,13+,15-,16-,17+,18-,19-/m0/s1
InChIKey
GJOPRRHPJJXPBD-XJOGIRLRSA-N
Synonyms
Palmarumycin B4; CHEMBL3342635
CAS NA
PubChem CID 101888372
ChEMBL ID CHEMBL3342635
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Benzenoids
      • Class: Naphthalenes
        • Subclass: No Rank at Level Subclass
          • Direct Parent: Naphthalenes

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 388.4 ALogp: -0.6
HBD: 5 HBA: 8
Rotatable Bonds: 0 Lipinski's rule of five: Accepted
Polar Surface Area: 132.0 Aromatic Rings: 6
Heavy Atoms: 28 QED Weighted: 0.395

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.806 MDCK Permeability: 0.00002220
Pgp-inhibitor: 0.003 Pgp-substrate: 0.942
Human Intestinal Absorption (HIA): 0.137 20% Bioavailability (F20%): 0.021
30% Bioavailability (F30%): 0.865

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.349 Plasma Protein Binding (PPB): 93.95%
Volume Distribution (VD): 0.453 Fu: 3.12%

ADMET: Metabolism

CYP1A2-inhibitor: 0.038 CYP1A2-substrate: 0.121
CYP2C19-inhibitor: 0.02 CYP2C19-substrate: 0.324
CYP2C9-inhibitor: 0.006 CYP2C9-substrate: 0.262
CYP2D6-inhibitor: 0.006 CYP2D6-substrate: 0.229
CYP3A4-inhibitor: 0.009 CYP3A4-substrate: 0.081

ADMET: Excretion

Clearance (CL): 7.659 Half-life (T1/2): 0.504

ADMET: Toxicity

hERG Blockers: 0.043 Human Hepatotoxicity (H-HT): 0.988
Drug-inuced Liver Injury (DILI): 0.516 AMES Toxicity: 0.521
Rat Oral Acute Toxicity: 0.738 Maximum Recommended Daily Dose: 0.66
Skin Sensitization: 0.288 Carcinogencity: 0.972
Eye Corrosion: 0.003 Eye Irritation: 0.013
Respiratory Toxicity: 0.979
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC001988 0.784 D0Q3VE 0.264
ENC003196 0.736 D06ALD 0.237
ENC003195 0.717 D06BQU 0.229
ENC003194 0.629 D01TNW 0.217
ENC002185 0.570 D00JRA 0.212
ENC002330 0.559 D0Z1FX 0.211
ENC003239 0.559 D0O6IZ 0.210
ENC003198 0.524 D03DXN 0.207
ENC003238 0.514 D08DFX 0.203
ENC001999 0.495 D08CCE 0.198
*Note: the compound similarity was calculated by RDKIT.